| P50 | author | Don C Des Jarlais | Q59824152 |
| | Aimee N C Campbell | Q87177142 |
| P2093 | author name string | Susan Tross | |
| | Margaret Wolff | |
| | Laurel Weaver | |
| P2860 | cites work | Depression and HIV risk behaviors among patients in a sexually transmitted disease clinic | Q39683833 |
| | Evolving views and practices of antiretroviral treatment prescribers in Australia. | Q41250618 |
| | Stimulant-induced enhanced sexual desire as a potential contributing factor in HIV transmission | Q43630457 |
| | Provider barriers to prescribing HAART to medically-eligible HIV-infected drug users | Q43752658 |
| | Trends in HIV diagnoses and testing among U.S. adolescents and young adults | Q44904692 |
| | Factors influencing physicians' judgments of adherence and treatment decisions for patients with HIV disease | Q46238724 |
| | Stimulant use and sexual risk behaviors for HIV in rural North Carolina | Q46396331 |
| | Clinician Practices and Attitudes Regarding Early Antiretroviral Therapy in the US | Q57980464 |
| | Associations Between Alcohol, Heroin, and Cocaine Use and High Risk Sexual Behaviors Among Detoxification Patients | Q58289995 |
| | Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City | Q79467308 |
| | Hospitalized HIV-infected patients in the era of highly active antiretroviral therapy | Q83668498 |
| | Prevention of HIV-1 infection with early antiretroviral therapy | Q24634688 |
| | Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons | Q28353070 |
| | Barriers to Universal Prescribing of Antiretroviral Therapy by HIV Care Providers in the United States, 2013-2014. | Q33864063 |
| | Never in care: characteristics of HIV-infected crack cocaine users in 2 US cities who have never been to outpatient HIV care | Q33925086 |
| | Neurocognitive impairment and HIV risk factors: a reciprocal relationship | Q34005620 |
| | Factors informing HIV providers' decisions to start antiretroviral therapy for young people living with behaviorally acquired HIV. | Q34084817 |
| | Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection | Q34485916 |
| | A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa | Q34485938 |
| | Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals | Q34524937 |
| | The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic | Q34554572 |
| | Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users | Q34743004 |
| | Attitudes and Training Needs of New England HIV Care and Addiction Treatment Providers: Opportunities for Better Integration of HIV and Alcohol Treatment Services | Q35136597 |
| | Enhanced HIV testing, treatment, and support for HIV-infected substance users | Q35253978 |
| | Clinician Perspectives on Delaying Initiation of Antiretroviral Therapy for Clinically Eligible HIV-Infected Patients | Q35589224 |
| | Knowledge, Beliefs and Practices Regarding Antiretroviral Medications for HIV Prevention: Results from a Survey of Healthcare Providers in New England | Q35683071 |
| | Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers | Q35835854 |
| | Antiretroviral medication treatment for all HIV-infected individuals: a protocol using innovative multilevel methodologies to evaluate New York City's universal ART policy among problem substance users. | Q36093277 |
| | The methamphetamine epidemic: implications for HIV prevention and treatment | Q36338896 |
| | Diffusion of Newer HIV Prevention Innovations: Variable Practices of Frontline Infectious Diseases Physicians | Q36369137 |
| | Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians | Q36416746 |
| | Negotiating substance use stigma: the role of cultural health capital in provider-patient interactions. | Q36837745 |
| | Initiation of antiretroviral therapy in youth with HIV: a U.S.-based provider survey | Q37139616 |
| | Antiretroviral Therapy for the Prevention of HIV-1 Transmission | Q37308674 |
| | Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations. | Q37626326 |
| | Social and structural factors associated with HIV disease progression among illicit drug users: a systematic review | Q37638817 |
| | Clinician practices and attitudes regarding early antiretroviral therapy in the United States | Q37642644 |
| | A guiding framework and approach for implementation research in substance use disorders treatment | Q37858524 |
| | HIV treatment as prevention among injection drug users | Q37974038 |
| | HIV treatment as prevention: how scientific discovery occurred and translated rapidly into policy for the global response | Q39245198 |
| P433 | issue | 3 | |
| P304 | page(s) | 1006-1017 | |
| P577 | publication date | 2017-12-20 | |
| P1433 | published in | AIDS and Behavior | Q15752229 |
| P1476 | title | "It's Never Just About the HIV:" HIV Primary Care Providers' Perception of Substance Use in the Era of "Universal" Antiretroviral Medication Treatment | |
| P478 | volume | 22 | |